CRYSTAL HAYES: Open Payments
NPI 1447812961 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 33 payments from 10 companies in 2025. Trend: 2023 $157 · 2024 $1,167 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $152 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Alkermes, Inc. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: CAPLYTA, Auvelity, INGREZZA, REXULTI, ARISTADA, VIVITROL, FANAPT, ABILIFY MAINTENA.
Industry payments across WV — which companies pay providers there.
